Quest Diagnostics (NYSE:DGX) Hits New 1-Year High After Analyst Upgrade
Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report) hit a new 52-week high during trading on Tuesday after Piper Sandler raised their price target on the stock from $180.00 to $200.00. Piper Sandler currently has a neutral rating on the stock. Quest Diagnostics traded as high as $179.16 and last traded at $178.35, with a […]
